Wellnex Life Limited (ASX:WNX)

Market Cap	5.92M -59.4%
Revenue (ttm)	24.84M +5.1%
Net Income	-4.55M
EPS	-0.14
Shares Out	73.03M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,529
Open	0.0780
Previous Close	0.0810
Day's Range	0.0780 - 0.0810
52-Week Range	0.0420 - 0.2750
Beta	1.32
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Wellnex Life

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2011
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: WNX

Financial Performance

In fiscal year 2026, Wellnex Life's revenue was 24.84 million, an increase of 5.13% compared to the previous year's 23.63 million. Losses were -4.55 million, -70.85% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 15, 2026

Data Sources Report a data error